title: Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada.
abstract: OBJECTIVE
  To estimate the prevalence of insulin resistance syndrome (IRS) in a representative sample of youth. To test for the independent contribution of insulin resistance (IR) and adiposity to clustering of metabolic risk factors. To identify the underlying components of IRS. To examine the relationship between adiposity and fasting plasma levels of free fatty acids (FFA).
  
  
  METHODS
  In 1999, we conducted a school-based survey of a representative sample of youth aged 9, 13 and 16 y in Quebec, Canada. Age-specific questionnaire data, standardized clinical measurements and a fasting blood sample were available for 2244 subjects. Fasting insulin and HOMA were used as surrogate measures of IR.
  
  
  RESULTS
  In all age-sex groups, adiposity indices, blood pressure (BP), plasma glucose and triglycerides (TG) increased significantly with increasing insulin quartiles while HDL cholesterol (HDL-C) decreased. The overall prevalence of IRS defined as hyperinsulinaemia combined with two or more risk factors including overweight, high systolic BP, impaired fasting glucose, high TG and low HDL-C, was 11.5% (95% CI: 10.2-12.9). There were no significant differences in the prevalence of IRS across ages or between sexes. The independent contribution of adiposity to clustering of risk factors was stronger than that of fasting insulin (or HOMA-IR). Factor analysis revealed three factors (BMI/insulin/lipids, BMI/insulin/glucose and diastolic/systolic BP) consistent across ages suggesting that more than one pathophysiologic process underlies IRS. Although elevation of FFA might be in the causal pathway linking obesity to IR, we did not detect any consistent association between measures of fatness and fasting plasma FFA.
  
  
  CONCLUSIONS
  IRS is highly prevalent in youth, even among children as young as age 9 y. Factor analysis identifies three physiologic domains within IRS with a unifying role for markers of IR and adiposity.
authors.affiliation: Department of Pediatrics, Ste-Justine Hospital and University of Montreal, Montreal, Quebec, Canada. marie.lambert@umontreal.ca
authors.forename: M
authors.initials: M
authors.lastname: Lambert
authors.forename: G
authors.initials: G
authors.lastname: Paradis
authors.forename: J
authors.initials: J
authors.lastname: O'Loughlin
authors.forename: E E
authors.initials: EE
authors.lastname: Delvin
authors.forename: J A
authors.initials: JA
authors.lastname: Hanley
authors.forename: E
authors.initials: E
authors.lastname: Levy
mesh_terms: D000293:Adolescent; D017677:Age Distribution; D000886:Anthropometry; D001794:Blood Pressure; D002648:Child; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006306:Health Surveys; D006801:Humans; D007333:Insulin Resistance; D008055:Lipids / Q000097:blood; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000453:epidemiology* / Q000503:physiopathology; D015995:Prevalence; D011792:Quebec / Q000453:epidemiology; D012307:Risk Factors; D017678:Sex Distribution
chemical_list: D005230:Fatty Acids, Nonesterified; D008055:Lipids